Covington, Freshfields-Led Biotech Co. Nabs $251M Financing
Cancer and infectious diseases-focused biotechnology company BioNTech said Monday it received a $251 million private investment from investors, including Singaporean government investment company Temasek Holdings, in a deal advised on by...To view the full article, register now.
Already a subscriber? Click here to view full article